IO Biotech Q4 Earnings Fall Short, Future Outlook Uncertain
Wednesday, 6 March 2024, 08:39
IO Biotech Earnings Update
The latest earnings release from IO Biotech shows a Q4 GAAP EPS of -$0.40, falling short of analyst estimates by $0.02. The company's financial standing remains a topic of concern as it closed 2023 with cash and cash equivalents worth about $143.2 million.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.